Norges Bank
ARIA

Norges Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Norges Bank’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,339,750
Closed -$29.1M – 2238
2016
Q4 		$29.1M Buy
2,339,750
+139,730
+6% +$1.68M 0.01% 1042
2016
Q3 		$28.8M Buy
2,200,020
+156,027
+8% +$1.57M 0.01% 965
2016
Q2 		$15.1M Buy
2,043,993
+378,000
+23% +$2.84M 0.01% 1373
2016
Q1 		$10.6M Hold
1,665,993
– – 0.01% 1528
2015
Q4 		$10.4M Hold
1,665,993
– – 0.01% 1565
2015
Q3 		$9.73M Buy
1,665,993
+122,549
+8% +$944K 0.01% 1571
2015
Q2 		$12.8M Buy
1,543,444
+248,722
+19% +$2.2M 0.01% 1473
2015
Q1 		$10.7M Sell
1,294,722
-200,632
-13% -$1.48M 0.01% 1606
2014
Q4 		$10.3M Sell
1,495,354
-627,761
-30% -$3.93M 0.01% 1627
2014
Q3 		$11.5M Sell
2,123,115
-2,123,115
-50% -$12.4M 0.01% 1521
2014
Q2 		$27.1M Buy
4,246,230
+2,123,115
+100% +$14.6M 0.01% 1441
2014
Q1 		$17.1M Hold
2,123,115
– – 0.01% 1236
2013
Q4 		$14.5M Sell
2,123,115
-436,681
-17% -$2.36M 0.01% 1343
2013
Q3 		$47.1M Buy
2,559,796
+1,794,489
+234% +$34.8M 0.03% 604
2013
Q2 		$13.4M Buy
+765,307
New +$13.6M 0.01% 1294

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Norges Bank's ARIA Position: Q1 2017 in Review

Norges Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 2,339,750 shares — an estimated $29.1M sold.

Norges Bank first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $47.1M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Norges Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Norges Bank sold 2,339,750 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $29.1M.
  • Norges Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Norges Bank's Ariad Pharmaceuticals Inc position peaked at $47.1M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Norges Bank's 13F filing for Q1 2017, filed 10 May 2017.